Fitbit-based cardiometabolic risk reduction intervention: randomized controlled trial.
Wearable device-based intervention reduces cardiometabolic risk factors, relevant to digital health approaches for cardiometabolic prevention.
This RCT evaluates a Fitbit-based cardiometabolic risk reduction program; outcomes and sample size require abstract retrieval for complete assessment. The digital health + cardiometabolic intersection is directly relevant to GLP-1/cardiometabolic watchlist topic.
What the study was
- Study design
- Parallel-arm randomized controlled trial
- Population
- Adults with cardiometabolic risk factors
- Category
- Prevention
- Maturity
- Validated
- Journal
- JMIR mHealth and uHealth
Why it surfaced
RCT design applied to Fitbit digital health intervention for cardiometabolic risk; JMIR mHealth; directly implementable population health tool.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.